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Vascular oxidative stress 
A B S T R A C T   
Background and aims: Underlying mechanisms associated with vascular dysfunction in metabolic syndrome 
(MetS) remain unclear and can even vary from one vascular bed to another. 
Methods: In this study, MetS was induced by a high-fat, high-sucrose diet, and after 28 weeks, aorta and renal 
arteries were removed and used for isometric recording of tension in organ baths, protein expression by Western 
blot, and histological analysis to assess the presence of atherosclerosis. 
Results: MetS induced a mild hypertension, pre-diabetes, central obesity and dyslipidaemia. Our results indicated 
that MetS did not change the contractile response in either the aorta or renal artery. Conversely, vasodilation was 
affected in both arteries in a different way. The aorta from MetS showed vascular dysfunction, including lower 
response to acetylcholine and sodium nitroprusside, while the renal artery from MetS presented a preserved 
relaxation to acetylcholine and an increased sensitivity to sodium nitroprusside. We did not find vascular 
oxidative stress in the aorta from MetS, but we found a significant decrease in PPARγ, phospho-Akt (p-Akt) and 
phospho-eNOS (p-eNOS) protein expression. On the other hand, we found oxidative stress in the renal artery 
from MetS, and PPARγ, Akt and p-Akt were overexpressed. No evidence of atherosclerosis was found in arteries 
from MetS. 
Conclusions: MetS affects vascular function differently depending on the vessel. In the aorta, it decreases both the 
vasodilation and the expression of the PPARγ/Akt/eNOS pathway, while in the renal artery, it increases the 
expression of PPARγ/Akt signalling pathway without decreasing the vasodilation.   
1. Introduction 
Metabolic syndrome (MetS) is a condition involving a set of risk 
factors for cardiovascular disease and diabetes, such as central 
adiposity, decreased high-density lipoprotein cholesterol (cHDL) plasma 
concentration, hypertriglyceridaemia, hypertension and dysglycaemia. 
Diagnosis of MetS requires the presence of at least three of them [1]. 
Vascular disorders are central in this condition, and endothelial 
dysfunction, involving a decrease in nitric oxide (NO) bioavailability is 
classically associated with cardiovascular risk factors. Endothelial NO, 
synthesized from L-arginine by endothelial nitric oxide synthase (eNOS), 
preserves vascular homeostasis through its vasodilator effect, and pre-
vents platelet adhesion and aggregation [2]. Moreover, NO has 
anti-inflammatory actions and inhibits smooth muscle cell proliferation 
[3]. Oxidative stress can decrease NO bioavailability and consequently 
lead to endothelial dysfunction. In the vascular wall, NADPH oxidase 
(Nox) is the main source of reactive oxygen and nitrogen species (RONS) 
by producing superoxide anion (O2− ), which can be degraded by su-
peroxide dismutase (SOD), or interact with NO to generate peroxynitrite 
(ONOO− ), reducing NO bioavailability [4]. Nox activity mainly depends 
on Nox4 in the vascular wall [5], and Cu/Zn-SOD is the major antioxi-
dant defence in blood vessels [6]. 
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Vascular function can also be affected by the peroxisome 
proliferator-activated receptor-γ (PPARγ) activity, a member of nuclear 
receptor super-family with anti-inflammatory effects [7]. It is involved 
in glucose and lipid metabolism, by enhancing insulin sensitivity and 
promoting lipogenesis. PPARγ is expressed in vascular cells and has a 
protective role on the vasculature [8,9]. PPARγ agonists have been 
demonstrated to improve endothelial function by enhancing eNOS 
phosphorylation and activity [10], though the specific underlying 
mechanisms are unclear. The regulation of eNOS activity implies the 
phosphorylation on Ser-1177 and Thr-495 and it is a complex process 
involving protein kinases, such as AMP activated protein kinase (AMPK) 
and Akt, also called protein kinase B [11]. Indeed, Akt increases eNOS 
activation through the phosphorylation on Ser-1177 [12]. 
We hypothesise that vascular dysfunction induced by MetS can be 
associated with vascular oxidative stress and/or an impairment in 
PPARγ signalling pathway. Therefore, we first tested whether our model 
of MetS altered the vascular reactivity, and second, we explored the 
involvement of vascular oxidative stress and PPARγ/Akt/eNOS 
pathway. Since the mechanisms implicated in vascular dysfunction and 
their adaptive responses can vary depending on the vascular bed, we 
carried out a comparative study using the abdominal aorta and renal 
artery. 
2. Materials and methods 
2.1Ethical approval 
The Bioethics Committee of the School of Medicine of the University 
of Valencia, Spain approved the present study, in accordance with the 
European Directive 2010/63/EU. Granja San Bernardo, Navarra, Spain 
provided and transported the animals under conditions specified in the 
Real Decreto 53/2013 (Spain). Animals were housed according to Uni-
versity of Valencia guidelines (12:12 h light/dark cycle at a constant 
room temperature of 22 ◦C and 60 % humidity). Rabbits were euthan-
ised with pentobarbital 100 mg kg− 1 IV. 
2.2. Animals and study design 
Twenty-four male New Zealand white rabbits (Oryctolagus cuniculus) 
were used in the present study, and were randomly assigned to control 
(n = 12) or MetS group (n = 12). Rabbits were fed during 28 weeks with 
120 g of standard rabbit chow (V2333-000, Ssniff, Soest, Germany), or 
with a high-fat and high-sucrose diet ad libitum to induce MetS (10 % 
hydrogenated coconut oil, 5 % lard; S9052-E020, Ssniff, Soest, Germany 
and high-sucrose 15 % dissolved in water). Control diet contained 23.4 
% protein, 11.1 % fat and 65.5 % carbohydrates (2.7 kcal g-1). High-fat 
diet was composed by 15.7 % protein, 43.1 % fat and 41.2 % carbohy-
drates (3.7 kcal g-1), and the animals consumed 0.6 kcal mL-1 in the 
drinking solution. The diet used in this study has previously showed its 
efficacy in inducing the main clinical and biochemical manifestations of 
MetS [13], namely central obesity, hypertension, pre-diabetes, and 
dyslipidaemia with low HDL and high LDL levels and hyper-
triglyceridaemia (see Supplementary Table S1). After the sacrifice, ar-
teries were removed and mounted for isometric recording of tension 
experiments, stored at − 20 ◦C for the protein expression measurement, 
or in formalin for histological analysis. 
2.3. Organ bath experiments 
Arteries were cleaned and cut into 3 mm length rings to study the 
vascular reactivity by isometric recording of tension. Two L-shaped 
stainless steel wires were introduced through the lumen of the vessel. 
One of them was fixed to the wall of the organ bath and the other one 
was connected to a force-displacement transducer (FT03; Grass In-
struments, West Warwick, RI, USA). Changes in isometric force were 
recorded on a Macintosh computer (Apple Corp., Cupertino, CA, USA) 
using Chart, version 7 and a MacLab/8e data acquisition system 
(ADInstruments). Each arterial segment was suspended in a 4 mL bath 
containing modified Krebs–Henseleit solution composed of (mM) 115 
NaCl, 4.6 KCl, 1.2 MgCl2⋅6H2O, 2.5 CaCl2, 25 NaHCO3, 11.1 glucose and 
disodium 0.01 EDTA and equilibrated with 95 % O2 and 5 % CO2 to 
obtain a pH about 7.35. Temperature was held at 37 ◦C. The optimal 
resting tension for abdominal aorta was 3 g and for renal artery was 1 g. 
After 2 h accommodation period, concentration response curves to KCl 
(5–100 mM), noradrenaline (10− 9 – 3x10− 5) and endothelin-1 (10− 12 
-10− 7 M) were performed in order to study both agonist-independent 
and -dependent contractile response. To examine the vasodilator 
response, vascular rings were precontracted with noradrenaline (10− 7 to 
3x10− 7 M, to obtain a contraction around 75 % of the maximal 
contraction to KCl 100 mM of each vascular ring) and then, the con-
centration response curves to acetylcholine and sodium nitroprusside 
were performed for the study of endothelium-dependent and -indepen-
dent vasodilator response, respectively. 
2.4. Western blot analysis 
Vascular tissues were homogenized in lysis buffer (0.125 M Tris-HCl, 
pH 6.8, 2 % SDS, 19 % glycerol and 1 % v/v protease inhibitors) and 
centrifuged at 12,000g for 15 min at 4 ◦C. Protein concentration was 
determined using a modified Lowry method [14]. Then, 0.5 % (v/v) 
2-mercaptoethanol and 1 % bromophenol blue were added and the 
samples were heated for 5 min at 90 ◦C. Proteins (25 μg) were separated 
on SDS-PAGE gels and transferred to nitrocellulose membranes in a 
humid environment using a transfer buffer (25 mM Tris, 190 mM glycine 
and 20 % methanol). Primary antibodies were incubated overnight at 
4 ◦C. The primary antibodies used were polyclonal Nox4 antibody 
(NB110–58849SS; dilution 1:500; Norvus Biologicals); polyclonal 
Cu/Zn-SOD antibody (SOD1; dilution 1:500; catalogue no. 
ADI-SOD-101; Enzo Life Sciences, Farmingdale, NY, USA); monoclonal 
Mn-SOD antibody (SOD2; dilution 1:500; catalogue no. sc-137,254; 
Santa Cruz Biotechnology, Santa Cruz, CA, USA); polyclonal eNOS 
antibody (Ab-1177; dilution 1:1000; catalogue no. 21170–2; 
Signalway-Antibody, CollegePark, MD, USA); polyclonal p-eNOS anti-
body (p-eNOS Ser-1177 sc-12972; dilution 1:500; Santa Cruz Biotech-
nology, Santa Cruz, CA, USA); monoclonal PPARγ antibody 
(MA5-14889; dilution 1:1000; Thermo Fisher Scientific), monoclonal 
Akt1 antibody (sc-5298; dilution 1:500; Santa Cruz, CA, USA), and 
monoclonal p-Akt1 antibody (p-Akt1 Ser-473 sc-293,125; dilution 
1:500; Santa Cruz, CA, USA). Then, membranes were washed three times 
with wash buffer TBS + Tween 20 and incubated for 1 h at room tem-
perature with the secondary antibodies anti-rabbit IgG, HRP-linked 
antibody (dilution 1:1000; catalogue no. 7074; Cell Signalling Tech-
nology) or goat anti-mouse IgG (H + L) secondary antibody, HRP 
(dilution 1:10,000; catalogue no. 31430; Thermo Fisher Scientific, 
Waltham, MA, USA). We used for the antibody detection a chem-
iluminescence method (Amersham Biosciences, Barcelona, Spain). 
Autoradiography signals were assessed using the digital image system 
ImageQuant LAS 4000 (GE Healthcare, Little Chalfont, UK). We used as 
a control for the amount of protein the primary monoclonal antibody 
α-tubulin (B-7) (dilution 1:1000; catalogue no. sc 5286; Santa Cruz 
Biotechnology). 
2.5. Histological analysis 
Tissue samples from both aorta and renal arteries were fixed in 
neutral-buffered formalin and processed by the standard procedure to be 
embedded in paraffin, sectioned, and stained with haematoxylin-eosin 
and with Masson’s Trichrome Stain Kit Artisan (Agilent, Santa Clara, 
CA, US). The presence of macrophages was assessed by immunostaining 
using the avidin-biotin-peroxidase method and CD68 monoclonal anti-
body (Dako, Glostrup, Denmark). 
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2.6. Statistical analysis 
Maximal effect (Emax) was expressed in mg for KCl concentration- 
response curves, or as a percentage of maximal contraction to KCl 
(100 mM) for noradrenaline and endothelin-1 concentration-response 
curves. Vasodilator response was expressed as the percentage of relax-
ation respect to the contractile tone induced by noradrenaline. 
Sensitivity is expressed as EC50, concentration of substance causing 
50 % of the maximal effect, for KCl, and as pD2, –log EC50, for 
noradrenaline and endothelin-1. Relaxation is expressed as a percentage 
of inhibition of noradrenaline-induced contraction. Values are expressed 
as the mean ± SEM for organ bath experiments or mean ± SD for 
Western blot analysis. Values were compared by an unpaired t-test and 
one- or two-way ANOVA. Bonferroni correction was applied for pairwise 
comparisons. p < 0.05 was considered statistically significant. 
3. Results 
3.1. Effects of MetS on vascular reactivity 
MetS did not change the concentration-response curves to KCl 
(5–100 mM), noradrenaline (10− 9-3x10− 5 M) and endothelin-1 (10− 12- 
10− 7 M), indicating that MetS did not modify any contractile mecha-
nism, dependent on or independent of agonist in either the aorta or renal 
artery (Fig. 1 and Supplementary Tables S2 and S3). 
In the aorta, the presence of MetS shifted the concentration-response 
curve to acetylcholine to the right, diminishing pD2 (from 7.51 ± 0.24 to 
6.60 ± 0.29, p= 0.034 for control and MetS, respectively) and Emax 
(from 88 ± 1 % to 69 ± 9 %, p= 0.028 for control and MetS, respectively) 
(Fig. 2A). MetS also shifted the relaxation curve to sodium nitroprusside 
to the right without changing pD2 but decreasing Emax (from 98 ± 1 % 
to 88 ± 3 %, p= 0.039 for control and MetS, respectively, Fig. 2C). On 
the other hand, in renal rings, MetS did not change the relaxation to 
acetylcholine (Fig. 2B) but increased the sensitivity to sodium nitro-
prusside (pD2 varied from 7.34 ± 0.13 in control to 7.72 ± 0.07 in MetS, 
p=0.030), without changes in the Emax (98 ± 1 % vs 100 ± 1 %, p=
0.160 for control and MetS, respectively, Fig. 2D). (Supplementary 
Tables S4 and S5). 
3.2. Effects of MetS on Nox4, Cu/Zn-SOD, Mn-SOD, PPARγ, Akt, p-Akt, 
eNOS and p-eNOS protein expression 
MetS did not alter Nox4, Cu/Zn-SOD and Mn-SOD protein expression 
in the aorta, however, in renal artery, MetS increased Nox4 (from 0.42 
± 0.07 in control to 1.59 ± 0.27 in MetS, p= 0.005) and decreased Cu/ 
Zn-SOD protein expression (from 1.28 ± 0.17 in control to 0.24 ± 0.16 
in MetS, p= 0.011) without changes in Mn-SOD (Fig. 3). 
Fig. 4 shows the changes induced by MetS in aorta. MetS significantly 
decreased PPARγ (from 1.25 ± 0.21 in control to 0.72 ± 0.12 in MetS, 
p= 0.008), p-Akt protein expression (from 0.59 ± 0.06 in control to 0.34 
± 0.08 in MetS, p= 0.026), and p-eNOS (from 0.55 ± 0.22 in control to 
0.10 ± 0.07 in MetS, p= 0.003) without modifying Akt and eNOS protein 
expression. The ratios between p-Akt/Akt (0.82 ± 0.06 in control and 
0.45 ± 0.04 in MetS, p=0.009) and p-eNOS/eNOS (0.86 ± 0.14 in 
control and 0.34 ± 0.05 in MetS, p=0.001) were lower in the aorta from 
MetS. 
Fig. 5 shows the changes induced by MetS in renal artery. In this 
vessel, MetS increased the protein expression of PPARγ (from 0.99 ±
0.13 in control to 2.12 ± 0.28 in MetS, p= 0.006), Akt (from 0.74 ± 0.06 
in control to 0.93 ± 0.03 in MetS, p= 0.011) and p-Akt (from 0.52 ± 0.13 
in control to 0.91 ± 0.10 in MetS, p= 0.014). The ratio between p-Akt/ 
Akt (0.68 ± 0.09 in control and 0.96 ± 0.11 in MetS, p=0.02) was higher 
in the renal artery from MetS. However, MetS did not alter the expres-
sion of eNOS, p-eNOS or the ratio between p-eNOS/eNOS in the renal 
artery. 
3.3. Histological analysis 
No evidence of atherosclerotic lesions was observed by histological 
procedures and there were no sign of pre-atherosclerotic changes as 
immunostaing of CD68 was negative in all the samples (Supplementary 
Fig. S1). 
4. Discussion 
Our model of MetS represents an early stage of the disease, with mild 
hypertension, pre-diabetes, central obesity, and alterations in the lipid 
profile (an increase in triglycerides and LDL, a decrease of HDL, and no 
changes in total cholesterol) [13], that begins damaging the aorta and 
triggering compensatory mechanisms in the renal artery. In addition, 
our findings underline that the model represents an incipient stage in the 
development of atherosclerosis and support that the changes in the 
Fig. 1. Concentration response to contractile agonists. 
Concentration–response curves to KCl (5–100 mM), noradrenaline (NA) (10− 9 
to 3 x 10− 5 M), and endothelin-1 (ET-1) (10− 12 to 10− 7 M) (A, C, and E for aorta 
and B, D and F for renal artery). Data are shown as mean ± SEM. 
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vasodilator response and alterations detected at the molecular level 
occur before the histological changes become evident. Some diets 
capable of inducing vascular alterations develop early compensatory 
mechanisms [15]. The advantage of studying the initial stages of a dis-
ease is to be able to detect the pathways that are damaged earlier, since 
they constitute promising therapeutic targets to slow the progression of 
the disease. 
Vascular alterations induced by our model were limited to relaxa-
tion. Controversy exists in the literature regarding vascular alterations 
induced by MetS. Whereas some authors found that a high-fat diet 
increased contractile response to noradrenaline, KCl, and angiotensin II 
in thoracic aorta from rabbits [16], others found a lesser response to 
noradrenaline in the thoracic aorta, and to noradrenaline, KCl and 
U46619 in small mesenteric arteries in mice [17]. In line with our re-
sults, a highly palatable cafeteria diet did not change the contractile 
response but reduced both endothelium-dependent and -independent 
vasodilation in rat mesenteric arteries [18]. These differences can be 
attributed to the vessel studied, animal species, and the experimental 
model. 
In the aorta, our results showed that MetS induced vascular 
dysfunction, since it decreased both pD2 value and maximal effect for 
the concentration-response curve to acetylcholine compared to the 
control group. This vascular dysfunction was not only an endothelial 
dysfunction; it was partly caused by a lower vascular smooth muscle 
capacity to vasodilate, as the sodium nitroprusside experiments indi-
cated. On the contrary, the renal artery from MetS developed an 
Fig. 2. Concentration response to vasodilator agonists. 
Relaxation–response curves to acetylcholine (ACh) (10− 9 to 3 x 10− 5 M) and sodium nitroprusside (SNP) (10− 9 to 3 x 10− 6 M) (A and C for aorta, and B and D for 
renal artery). Data are shown as mean ± SEM. 
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adaptive mechanism to preserve the vasodilation, keeping the relaxation 
to acetylcholine, and increasing the response to sodium nitroprusside. 
This result is noteworthy, because relaxation to NO donors enhances 
when there is an impairment of the eNOS-NO pathway. In this regard, 
Moncada et al. [19], found that sodium nitroprusside induced an in-
crease in cyclic guanosine monophosphate (cGMP), which is known to 
induce smooth muscle relaxation through NO, and a supersensitivity to 
nitrovasodilators can occur when the NO pathway is impaired [19]. This 
important adaptive mechanism allows the maintenance of vascular tone. 
In line with this argument, we hypothesise that, in the renal artery from 
MetS, the increased sensitivity of vascular smooth muscle cells to NO 
would prevent this vessel from endothelial dysfunction, which seems 
consistent with an early stage of vascular adaptation. 
MetS is related to oxidative stress [20,21], a situation due to an 
Fig. 3. Protein expression levels of Nox4, Cu/Zn-SOD and Mn-SOD. 
Protein expression levels of (A) Nox4, (B) Cu/Zn-SOD and (C) Mn-SOD in aorta and in renal artery from control and MetS. α-tubulin was used as internal control and 
the signal intensity was plotted as the ratio of target protein to α tubulin. Data are mean ± SD of 4 independent experiments. *p < 0.05 vs control. 
Fig. 4. Protein expression levels of PPARγ, eNOS, p-eNOS, Akt and p-Akt in aorta. 
Protein expression levels of (A) PPARγ, (B) eNOS, (C) p-eNOS, (F) Akt and (G) p-Akt in the aorta from control and MetS, and representative western blots for each 
antibody (E and I). α-tubulin was used as internal control and the signal intensity was plotted as the ratio of target protein to α-tubulin. (D and H) represents the ratio 
of p-eNOS/eNOS and p-Akt/Akt. Data are mean ± SD of 4 independent experiments. *p < 0.05 vs control. 
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imbalance in the production between pro-oxidants and antioxidants in 
favour of the former, which is also associated with vascular dysfunction. 
To evaluate if MetS induces oxidative stress in the vascular wall, we 
measured the protein expression of Nox4, Cu/Zn-SOD and Mn-SOD and 
we found vascular oxidative stress only in the renal artery from MetS. 
Therefore, the vascular dysfunction induced by MetS in the aorta is not 
related to oxidative stress. Surprisingly, in the renal artery from MetS 
the endothelium dependent vasodilation is the same that the one ob-
tained for control group, and the endothelium-independent vasodilation 
is even enhanced. Consequently, we can say that the renal artery from 
MetS has a preserved vasodilation. One can expect that the oxidative 
stress found in the renal artery from MetS leads to a dysfunction, but we 
also found a PPARγ overexpression, with the beneficial vascular effects 
previously described by others [8–10] that, on the basis of our results, 
prevails over the possible negative effects of oxidative stress. 
PPARγ is considered a cardiovascular protective agent and an 
alteration in its function is involved in many diseases such as diabetes or 
obesity [22]. PPARγ activation regulates AMPK/eNOS pathway, prob-
ably via Akt phosphorylation [23], and the inhibition of PPARγ signif-
icantly suppresses AMPK phosphorylation, eNOS expression and nitric 
oxide production. Akt is a protein kinase that contributes to phosphor-
ylate different proteins and has important metabolic effects; conse-
quently, its downregulation is associated with several pathologies 
including cancer, diabetes and neurocardiovascular diseases. Some ki-
nases are known to be capable of activating Akt through the phos-
phorylation on Ser-473 24. Once Akt is turned into p-Akt, it can 
phosphorilate eNOS on Ser-1177, thus activating the enzyme and pro-
ducing more NO [25]. According to our results, the aorta from MetS 
showed a reduction in PPARγ, p-Akt/Akt and p-eNOS/eNOS ratios. 
PPARγ can activate several signalling pathways implicating kinases 
which could phosphorylate Akt [24]. Consequently, if PPARγ was 
underexpressed, p-Akt could decrease without changes in Akt, as our 
results showed. Hence, a lower activation of eNOS through phosphor-
ylation on Ser-1177 would lead to a lower p-eNOS/eNOS ratio and 
consequently a decrease in NO production. Thus, we propose that in 
aorta from MetS the impaired vasodilation induced by acetylcholine is 
partly due to a downregulation in PPARγ, which can reduce downstream 
the activity of eNOS. 
As we discussed above, in the aorta, MetS not only significantly 
shifted the concentration-response curve to acetylcholine to the right, 
but also decreased Emax to sodium nitroprusside, indicating that there is 
another mechanism affecting vascular function, which is endothelium- 
independent. Qu et al. [26] demonstrated that some PPAR agonists act 
independently of endothelial NO. Halabi et al. [27] demonstrated that 
transgenic mice overexpressing the same dominant negative mutation in 
PPARγ which causes hypertension in humans, exhibited an impaired of 
both nitric oxide endothelium-dependent and -independent relaxation 
when compared to non-transgenic mice and wild-type PPARγ mice. 
Therefore, PPARγ, as a transcription factor, would modulate multiple 
signalling pathways including endothelium-dependent and 
-independent. 
In the renal artery, where MetS increased the sensitivity of vascular 
smooth muscle cells to NO, mechanism that can prevent this vessel from 
endothelial dysfunction [19], we found an increase in the protein 
expression of PPARγ and p-Akt/Akt ratio. Thus, we propose that the 
activation of the PPARγ/Akt signalling pathway could explain the 
compensatory mechanism to keep vasodilation in this vessel, indicating 
that the positive effects derived from the activation of this pathway 
prevails over negative effects induced by oxidative stress. Despite 
overexpression of the PPARγ/Akt signalling pathway in the renal artery 
from MetS, it did not modify eNOS phosphorylation on Ser-1177, indi-
cating that eNOS activation is not increased in this group. This is 
consistent with the unchanged vasodilation response to acetylcholine 
observed in the renal artery from MetS. The fact that an increase in 
Fig. 5. Protein expression levels of PPARγ, eNOS, p-eNOS, Akt and p-Akt in renal artery. 
Protein expression levels of (A) PPARγ, (B) eNOS, (C) p-eNOS, (F) Akt and (G) p-Akt in the renal artery from control and MetS, and representative western blots for 
each antibody (E and I). α-tubulin was used as internal control and the signal intensity was plotted as the ratio of target protein to α-tubulin. (D and H) represents the 
ratio of p-eNOS/eNOS and pAkt/Akt. Data are mean ± SD of 4 independent experiments. *p < 0.05 vs control. 
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p-AKt in the renal artery from MetS does not result in an increase in 
eNOS phosphorylation is not surprising, because of the complicated 
regulation of eNOS activity by phosphorylation, which implies multiple 
protein kinases and phosphatases. Accordingly, eNOS phosphorylation 
on Ser-1177 activates the enzyme whereas phosphorylation on Thr-495 
inactivates eNOS. For instance, Akt, cAMP-dependent protein kinase 
(PKA), AMP-activated protein kinase (AMPK) and the protein ser-
ine/threonine phosphatase 1 (PP1) activate eNOS by phosphorylation 
on Ser-1177 (the first three) or dephosphorylation on Thr-495 (the last 
one). Conversely, protein kinase C (PKC) or the protein serine/threonine 
phosphatase 2 (PP2) inhibit eNOS activity by phosphorylating Thr-495 
and dephosphorylating Ser-1177, respectively [11]. Therefore, and 
because of the highly coordinated regulation of eNOS activity, MetS 
could also be affecting any of these mechanisms, and hence eNOS 
phosphorylation, which could explain why an overexpression in 
PPARy/Akt signalling pathway in the renal artery from MetS does not 
cause an increase in eNOS activation. In addition, these mechanisms can 
vary from one vascular bed to another. More studies are needed to delve 
into the vascular alteration mechanism underlying MetS. 
Finally, our results are in concordance to previous studies demon-
strating that rabbits only develop atherosclerosis when their diet con-
sists of 4 %–8 % fat per kilogram of weight and cholesterol is added (0.3 
%–2 %). Indeed, rabbits, as herbivores, are very sensitive to cholesterol 
and fats, and when diet contains up to 2 % cholesterol, a rapid rise in 
plasma cholesterol occurs, leading to atherosclerosis [28]. In our study, 
the diet inducing metabolic syndrome did not contain cholesterol; 
therefore, we expected rabbits to develop an early state of metabolic 
syndrome without atherosclerosis. 
It should be considered that our experimental protocol cannot 
discriminate between endothelial and smooth muscle cells when we 
determine the protein expression by Western blot from the total vascular 
tissue. What we can discriminate is if vasodilation is associated with 
endothelial NO or exogenous NO when we perform experiments in the 
organ bath (using acetylcholine or sodium nitroprusside, respectively) 
and both responses are altered in MetS. PPARγ signalling pathway could 
be connected with both, endothelial and smooth muscle cells function. 
Although in our study we focus on the PPARγ/Akt/eNOS pathway, 
which implies endothelial cells, we cannot rule out the non-endothelial 
effects of PPARγ activation. Our results show interesting correlations 
between an overexpression in PPARγ and an improvement in vasodila-
tion, indicating the more PPARγ expression in the vessel, the more 
endothelium-dependent and endothelium-independent vasodilatation 
occurs. However, more research would be needed to demonstrate a 
direct relationship. 
In conclusion, downregulation of PPARγ/Akt signalling pathway can 
inactivate eNOS through decreasing phosphorylation on Ser-1177, 
leading to endothelial dysfunction. Furthermore, this pathway could 
further activate endothelium-independent mechanisms to keep the 
vascular homeostasis. Accordingly, in the aorta from MetS, where the 
PPARγ/Akt/eNOS pathway is underexpressed, both endothelium- 
dependent and -independent vasodilation are impaired; on the other 
hand, the renal artery from MetS, where PPARγ/Akt signalling pathway 
is overexpressed, preserves endothelium-dependent vasodilation and 
even increases endothelium-independent vasodilation. 
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editing. José M. Vila: Investigation, Data curation, Writing – review & 
editing. Manuel Zarzoso: Conceptualization, Methodology, Validation, 
Resources, Project administration, Funding acquisition, Writing – re-
view & editing. Maria D. Mauricio: Conceptualization, Methodology, 
Data curation, Writing – original draft, Supervision, Project adminis-
tration, Writing – review & editing. 
Declaration of competing interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
Acknowledgements 
Thanks to Professor Luis Such and GRELCA Research Group, 
Department of Physiology, School of Medicine, University of Valencia, 
Spain, for their support in the animal model development. Thanks to 
Jude Moreland for his editorial assistance. 
Appendix A. Supplementary data 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.atherosclerosis.2021.08.006. 
References 
[1] K.G.M.M. Alberti, et al., Harmonizing the metabolic syndrome: a joint interim 
statement of the international diabetes federation task force on epidemiology and 
prevention; national heart, lung, and blood institute; American heart association; 
world heart federation; international atherosclerosis society; and international 
association for the study of obesity, Circulation 120 (2009) 1640–1645. 
[2] J.A. Mitchell, F. Ali, L. Bailey, L. Moreno, L.S. Harrington, Role of nitric oxide and 
prostacyclin as vasoactive hormones released by the endothelium, Exp. Physiol. 93 
(2008) 141–147. 
[3] C. Zhang, The role of inflammatory cytokines in endothelial dysfunction, Basic Res. 
Cardiol. 103 (2008) 398–406. 
[4] U. Förstermann, Nitric oxide and oxidative stress in vascular disease, Pflügers 
Archiv 459 (2010) 923–939. 
[5] S.H.M. Ellmark, G.J. Dusting, M.N.T. Fui, N. Guzzo-Pernell, G.R. Drummond, The 
contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle, 
Cardiovasc. Res. 65 (2005) 495–504. 
[6] Mendez J. Ignacio, J. Nicholson William, Taylor W. Robert, SOD isoforms and 
signaling in blood vessels, Arterioscler. Thromb. Vasc. Biol. 25 (2005) 887–888. 
[7] S. Villapol, Roles of peroxisome proliferator-activated receptor gamma on brain 
and peripheral inflammation, Cell. Mol. Neurobiol. 38 (2018) 121–132. 
[8] M.J. Cipolla, N. Bishop, R.S. Vinke, J.A. Godfrey, PPARγ activation prevents 
hypertensive remodeling of cerebral arteries and improves vascular function in 
female rats, Stroke 41 (2010) 1266–1270. 
[9] S.Z. Duan, M.G. Usher, R.M. Mortensen, Peroxisome proliferator-activated 
receptor-gamma-mediated effects in the vasculature, Circ. Res. 102 (2008) 
283–294. 
[10] N. Kobayashi, et al., Cardioprotective mechanism of telmisartan via PPAR-gamma- 
eNOS pathway in dahl salt-sensitive hypertensive rats, Am. J. Hypertens. 21 (2008) 
576–581. 
[11] B.J. Michell, et al., Coordinated control of endothelial nitric-oxide synthase 
phosphorylation by protein kinase C and the cAMP-dependent protein kinase, 
J. Biol. Chem. 276 (2001) 17625–17628. 
[12] M. Montagnani, H. Chen, V.A. Barr, M.J. Quon, Insulin-stimulated activation of 
eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179), 
J. Biol. Chem. 276 (2001) 30392–30398. 
[13] O.J. Arias-Mutis, et al., Development and characterization of an experimental 
model of diet-induced metabolic syndrome in rabbit, PloS One 12 (2017), 
e0178315. 
[14] G.L. Peterson, A simplification of the protein assay method of Lowry et al. which is 
more generally applicable, Anal. Biochem. 83 (1977) 346–356. 
[15] S.M. Chadderdon, et al., Temporal changes in skeletal muscle capillary responses 
and endothelial-derived vasodilators in obesity-related insulin resistance, Diabetes 
65 (2016) 2249–2257. 
S. Guerra-Ojeda et al.                                                                                                                                                                                                                          
Atherosclerosis 332 (2021) 16–23
23
[16] G. Alarcon, et al., High fat diet-induced metabolically obese and normal weight 
rabbit model shows early vascular dysfunction: mechanisms involved, Int. J. Obes. 
42 (2018) 1535–1543. 
[17] A.G. Soares, M.H.C. de Carvalho, E. Akamine, Obesity induces artery-specific 
alterations: evaluation of vascular function and inflammatory and smooth muscle 
phenotypic markers, Biomed Res Int 2017 (2017), 5038602. 
[18] E.K. Naderali, L.C. Pickavance, J.P. Wilding, G. Williams, Diet-induced endothelial 
dysfunction in the rat is independent of the degree of increase in total body weight, 
Clin. Sci. 100 (2001) 635–641. 
[19] S. Moncada, D.D. Rees, R. Schulz, R.M. Palmer, Development and mechanism of a 
specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide 
synthesis in vivo, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2166–2170. 
[20] A. Carrier, Metabolic syndrome and oxidative stress: a complex relationship, 
Antioxidants Redox Signal. 26 (2017) 429–431. 
[21] S. Spahis, J.-M. Borys, E. Levy, Metabolic syndrome as a multifaceted risk factor for 
oxidative stress, Antioxidants Redox Signal. 26 (2017) 445–461. 
[22] J. Hwang, et al., Peroxisome proliferator-activated receptor-gamma ligands 
regulate endothelial membrane superoxide production, Am. J. Physiol. Cell 
Physiol. 288 (2005) C899–C905. 
[23] L. Xu, et al., A protective role of ciglitazone in ox-LDL-induced rat microvascular 
endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway, J. Cell 
Mol. Med. 19 (2015) 92–102. 
[24] G.M. Nitulescu, et al., The Akt pathway in oncology therapy and beyond (Review), 
Int. J. Oncol. 53 (2018) 2319–2331. 
[25] H. Li, et al., Telmisartan attenuates monocrotaline-induced pulmonary artery 
endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS 
pathway, Pulm. Pharmacol. Therapeut. 28 (2014) 17–24. 
[26] C. Qu, S.W.S. Leung, P.M. Vanhoutte, R.Y.K. Man, Wy14643 improves vascular 
function in the aorta of the spontaneously hypertensive rat mainly by activating 
peroxisome proliferator-activated receptors alpha, Eur. J. Pharmacol. 696 (2012) 
101–110. 
[27] C.M. Halabi, et al., Interference with PPAR gamma function in smooth muscle 
causes vascular dysfunction and hypertension, Cell Metabol. 7 (2008) 215–226. 
[28] W.M. Lozano, O.J. Arias-Mutis, C.J. Calvo, F.J. Chorro, M. Zarzoso, Diet-induced 
rabbit models for the study of metabolic syndrome, Animals (Basel) 9 (2019). 
S. Guerra-Ojeda et al.                                                                                                                                                                                                                          
